Dalian BIO-CHEM Company Limited (SHA:603360)
19.65
-0.10 (-0.51%)
Jul 24, 2025, 3:00 PM CST
Dalian BIO-CHEM Company Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 297.11 | 345.26 | 328.38 | 402.57 | 250.49 | 221.75 | Upgrade |
Depreciation & Amortization | 69.65 | 69.65 | 64.04 | 71.01 | 48.22 | 42.49 | Upgrade |
Other Amortization | 0.48 | 0.48 | - | 0.51 | 1.1 | 0.79 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | - | -0.07 | - | -0.49 | Upgrade |
Asset Writedown & Restructuring Costs | 0.26 | 0.26 | 0.11 | 0.26 | 0.97 | - | Upgrade |
Loss (Gain) From Sale of Investments | -15.35 | -15.35 | -0.35 | 7.57 | -0.59 | -1.03 | Upgrade |
Provision & Write-off of Bad Debts | 7.24 | 7.24 | -1.43 | 0.83 | 4.1 | -2.64 | Upgrade |
Other Operating Activities | 73.74 | 31.52 | 17.11 | 0.8 | 11.66 | 26 | Upgrade |
Change in Accounts Receivable | -301.29 | -301.29 | -9.48 | 43.07 | -120.15 | -72.28 | Upgrade |
Change in Inventory | -25.42 | -25.42 | -25.9 | 6.58 | -81.45 | -24.01 | Upgrade |
Change in Accounts Payable | 47.9 | 47.9 | 6.71 | -73.08 | 1.29 | 20.18 | Upgrade |
Change in Other Net Operating Assets | 0.13 | 0.13 | 15.47 | 8.47 | - | - | Upgrade |
Operating Cash Flow | 157.05 | 162.98 | 389.69 | 479.9 | 142.03 | 210.62 | Upgrade |
Operating Cash Flow Growth | -29.46% | -58.18% | -18.80% | 237.90% | -32.57% | -12.27% | Upgrade |
Capital Expenditures | -79.28 | -74.91 | -67.35 | -134.28 | -191.61 | -109.2 | Upgrade |
Sale of Property, Plant & Equipment | 0.14 | 0.08 | 0.1 | 0 | 0.02 | 0 | Upgrade |
Divestitures | 31.03 | 31.03 | - | 12.25 | - | - | Upgrade |
Investment in Securities | -125 | - | -60 | - | 140 | -10 | Upgrade |
Other Investing Activities | 1.71 | 158.17 | 0.33 | -2.57 | 1.19 | 1.72 | Upgrade |
Investing Cash Flow | 328.6 | 114.36 | -126.92 | -124.61 | -50.4 | -117.48 | Upgrade |
Short-Term Debt Issued | - | - | - | 99 | 398.49 | 30 | Upgrade |
Long-Term Debt Issued | - | 355 | 149.97 | - | - | - | Upgrade |
Total Debt Issued | 745 | 355 | 149.97 | 99 | 398.49 | 30 | Upgrade |
Short-Term Debt Repaid | - | - | - | -337.99 | -261.28 | -60 | Upgrade |
Long-Term Debt Repaid | - | -270.9 | -129.43 | - | - | - | Upgrade |
Total Debt Repaid | -323.31 | -270.9 | -129.43 | -337.99 | -261.28 | -60 | Upgrade |
Net Debt Issued (Repaid) | 421.69 | 84.1 | 20.54 | -238.99 | 137.2 | -30 | Upgrade |
Issuance of Common Stock | - | - | 27.77 | 3.75 | 36.92 | - | Upgrade |
Repurchase of Common Stock | -500 | - | - | - | -45.11 | -154.89 | Upgrade |
Common Dividends Paid | -229.21 | -223.62 | -206.86 | -6.5 | -159.02 | -112.93 | Upgrade |
Other Financing Activities | 150.38 | 49.36 | -29.6 | 70.87 | -28.65 | 143.19 | Upgrade |
Financing Cash Flow | -157.15 | -90.17 | -188.16 | -170.86 | -58.66 | -154.63 | Upgrade |
Foreign Exchange Rate Adjustments | 8.58 | 7.69 | 3.4 | -0.2 | -0.53 | -0.04 | Upgrade |
Net Cash Flow | 337.09 | 194.86 | 78.01 | 184.23 | 32.44 | -61.54 | Upgrade |
Free Cash Flow | 77.78 | 88.07 | 322.33 | 345.62 | -49.58 | 101.41 | Upgrade |
Free Cash Flow Growth | -48.43% | -72.68% | -6.74% | - | - | -42.74% | Upgrade |
Free Cash Flow Margin | 5.47% | 6.71% | 30.25% | 27.50% | -4.93% | 13.53% | Upgrade |
Free Cash Flow Per Share | 0.11 | 0.12 | 0.46 | 0.50 | -0.07 | 0.14 | Upgrade |
Cash Interest Paid | - | - | - | - | 0.98 | 5.31 | Upgrade |
Cash Income Tax Paid | 107.53 | 61.44 | 36.41 | 44.77 | 37.56 | 51.53 | Upgrade |
Levered Free Cash Flow | -424.43 | -393.08 | 217.25 | -64.01 | -15.74 | 119.48 | Upgrade |
Unlevered Free Cash Flow | -417.28 | -388.89 | 219.7 | -61.69 | -8.39 | 124.28 | Upgrade |
Change in Net Working Capital | 644.57 | 643.19 | 27.74 | 285.89 | 62.82 | -31.41 | Upgrade |
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.